A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus (T2DM); Obesity Interventions: Drug: Placebo; Drug: Rosuvastatin; Drug: Midazolam; Drug: Omeprazole; Drug: PF-06954522 Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants
Conditions: Healthy Interventions: Drug: Caffeine Tablet; Drug: Omeprazole capsule; Drug: Warfarin tablet; Drug: LOXO-305 Sponsors: Eli Lilly and Company; Loxo Oncology, Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects
Conditions: Healthy Subjects Interventions: Drug: JAB-21822; Drug: Itraconazole; Drug: Omeprazole; Drug: Midazolam , Rosuvastatin calcium and digoxin; Drug: Rifampicin Sponsors: Jacobio Pharmaceuticals Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

An Drug-drug Interaction Study to Evaluate the Effects of Omeprazole 40mg on the Pharmacokinetics of SPRYCEL ®
Conditions: Drug-drug Interaction Study Interventions: Drug: SPRYCEL ® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg Sponsors: Xspray Pharma AB Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials

GERD Infant Feeding Therapeutics Trial (GIFT Trial)
Conditions: GERD in Infants Interventions: Drug: Omeprazole; Other: AR formula Sponsors: Nationwide Children ' s Hospital; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553
Conditions: Healthy Male Interventions: Drug: D-1553 Sponsors: InventisBio Co., Ltd Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials

Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects
Conditions: Malignant Tumor Interventions: Drug: SHR2554 tablet dosing; Drug: Omeprazole tablet dosing Sponsors: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials

Drug-durg Interaction of Leritrelvir With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin
Condition:   Drug Drug Interaction Interventions:   Drug: Midazolam;   Drug: Omeprazole;   Drug: Rosuvastatin;   Drug: Verapamil;   Drug: Rifampin;   Drug: Leritrelvir Sponsor:   Guangdong Raynovent Biotech Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials